Generic versions of a groundbreaking injectable HIV-prevention drug should be available for $40 a year in more than 100 ...

Discover how lenacapavir, a revolutionary HIV prevention tool, will be available for just $40 annually to 120 low- and middle ...

Lenacapavir is a long-acting injectable antiretroviral drug developed by Gilead Sciences. It is administered just twice a year and has demonstrated over 99.9% effectiveness in preventing HIV ...

Advances in HIV medication, its window of detection and its transmission risk within the last decade have led to an updated ...

A total of 636 new cases of Human Immunodeficiency Virus (HIV) infections have been recorded in the Ahafo Region in the first ...

Globally, 630,000 people died from HIV-related causes in 2024, while 1.3 million people acquired HIV, including 120,000 ...

The Malinauskas Government has today launched a new strategy to virtually eliminate HIV transmission in South Australia by 2030. Reaffirming our ...

To end new HIV infections in Nigeria by 2030, researchers at the Nigerian Institute of Medical Research, Yaba, Lagos, have stressed the need to scale up awareness in the area of prevention of ...

Lenacapavir has the potential to end the HIV epidemic, researchers say. The Trump administration says backing this kind of ...

The plan to target pregnant and breastfeeding mothers will be administered through PEPFAR. Critics said it appeared to ...